Figure S4 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer

Figure S4 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer

<p>Figure S4. Quantification of cell viability by MTT assay. Combined treatment of 50 and 20 µM oxaliplatin and 10 µM β-cryptoxanthin in (A) HCT116 and (B) SW480-ADH cells respectively, leads to similar percentage of cell viability reduction to those produced by a double dose of oxaliplatin...

Full description

Saved in:
Bibliographic Details
Main Author: Coral San Millán (14998140) (author)
Other Authors: Beatriz Soldevilla (457149) (author), Paloma Martín (144198) (author), Beatriz Gil-Calderón (14998143) (author), Marta Compte (7506) (author), Belén Pérez-Sacristán (457150) (author), Encarnación Donoso (14998146) (author), Cristina Peña (84374) (author), Jesús Romero (14998149) (author), Fernando Granado-Lorencio (457152) (author), Félix Bonilla (84380) (author), Gemma Domínguez (84375) (author)
Published: 2023
Subjects:
Cancer
Therapeutic Research and Development
Methods and Technology
Chemotherapy
Adjuvant chemotherapy
Combination chemotherapy
Drug Discovery Technologies
Natural products
Drug Resistance
Clinical drug resistance
Novel mechanisms
Regulation of gene expression in drug resistance
Reversal of drug resistance
Drug Targets
Gastrointestinal Cancers
Colorectal cancer
Small Molecule Agents
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items